title: Influence of defunctionalization and mechanical forces on intestinal epithelial wound healing.
abstract: The influence on mucosal healing of luminal nutrient flow and the forces it creates are poorly understood. We hypothesized that altered deformation and extracellular pressure mediate, in part, the effects of defunctionalization on mucosal healing. We created patent or partially obstructing defunctionalizing jejunal Roux-en-Y anastomoses in rats to investigate mucosal healing in the absence or presence of luminal nutrient flow and measured luminal pressures to document partial obstruction. We used serosal acetic acid to induce ulcers in the proximal, distal, and defunctionalized intestinal segments. After 3 days, we assessed ulcer area, proliferation, and phosphorylated ERK. In vitro, we measured proliferation and migration in Caco-2 and IEC-6 intestinal epithelial cells subjected to cyclic strain, increased extracellular pressure, or strain and pressure together. Defunctionalization of intestine without obstruction reduced phosphorylated ERK, slowed ulcer healing, and inhibited mucosal proliferation. This outcome was blocked by PD-98059. Partial obstruction delayed ulcer healing but stimulated proliferation independently of ERK. In vitro, strain increased Caco-2 and IEC-6 proliferation and reduced migration across collagen but reduced proliferation and increased migration across fibronectin. In contrast, increased pressure and the combination of pressure and strain increased proliferation and reduced migration independently of substrate. PD-98059 reduced basal migration but increased migration under pressure. These results suggest that loss of the repetitive distension may decrease mucosal healing in defunctionalized bowel, while increased luminal pressure above anastomoses or in spastic bowel disease could further inhibit mucosal healing, despite peristaltic repetitive strain. ERK may mediate the effects of repetitive deformation but not the effects of pressure.
authors.affiliation: Dept. of Surgery, College of Human Medicine, Michigan State Univ., Lansing, MI 48912, USA.
authors.forename: Pavlo L
authors.initials: PL
authors.lastname: Kovalenko
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Flanigan
authors.forename: Lakshmi
authors.initials: L
authors.lastname: Chaturvedi
authors.forename: Marc D
authors.initials: MD
authors.lastname: Basson
mesh_terms: D000713:Anastomosis, Roux-en-Y; D000818:Animals; D018938:Caco-2 Cells; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D005260:Female; D005419:Flavonoids / Q000494:pharmacology; D006801:Humans; D007413:Intestinal Mucosa / Q000502:physiology*; D007415:Intestinal Obstruction / Q000503:physiopathology; D007583:Jejunum / Q000293:injuries; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000502:physiology; D011312:Pressure / Q000009:adverse effects; D051381:Rats; D017208:Rats, Wistar; D014456:Ulcer / Q000628:therapy; D014945:Wound Healing / Q000502:physiology*
chemical_list: D005419:Flavonoids; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one